CTIX Upcoming and Past Milestones, Clinical Trials, Recent Interviews
Join Cellceutix in Reaching Milestones
2017 Goals = A Focus On Partnering Opportunities
Successfully Complete • Phase 2b Trial of Prurisol for Psoriasis • Phase 2a Trial of Brilacidin for UP/UPS (IBD) • Phase 2 Trial of Brilacidin for Oral Mucositis • Phase 2a Trial of Kevetrin for Ovarian Cancer • FDA Meetings: a) End of P2 for Psoriasis b) SPA for Brilacidin in ABSSSI
Meeting 2017 Milestones Sets the Stage to Potentially Initiate 5 Registration Studies in 2018!
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.